dichlororibofuranosylbenzimidazole has been researched along with Anaplastic Astrocytoma in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inhibiting protein synthesis by incubating C6-2B rat astrocytoma cells with cycloheximide or emetine for periods up to 24 hours caused a progressive decrease in the accumulation of adenosine 3',5'-monophosphate (cyclic AMP) when the cells were challenged for 30 minutes with 100 microM forskolin." | 3.66 | Selective reduction of forskolin-stimulated cyclic AMP accumulation by inhibitors of protein synthesis. ( Barovsky, K; Brooker, G; Pedone, C, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooker, G | 1 |
| Pedone, C | 1 |
| Barovsky, K | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Selective reduction of forskolin-stimulated cyclic AMP accumulation by inhibitors of protein synthesis.
Topics: Animals; Astrocytoma; Cell Line; Cholera Toxin; Colforsin; Cyclic AMP; Cycloheximide; Dichlororibofu | 1983 |